Related-Donor Bone Marrow Transplant at URMCResearch Question:
What is the safety and validity of the process for related donor haploidentical stem
cell transplantation at the Wilmot Cancer Institute Blood and Marrow Transplant Unit?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This study will be a single-center treatment protocol with five possible preparative
regimens, designed to validate the process of related donor haploidentical stem cell
transplantation at the Wilmot Cancer Institute Blood and Marrow Transplant Unit. Enrolled
patients will receive chemotherapy +/- radiation as a pre-transplant conditioning
regimen. Patients will then receive haploidentical stem cells, either bone marrow
or mobilized peripheral blood, followed by GvHD prophylaxis that will include cyclophosphamide.
Multiple data points will be collected prior to, during, and following transplantation
to ensure safety of the process and to evaluate the stated objectives.
Study Reference #: UBMT15056-
Lead Researcher (Principal Investigator)
Lead Researcher: Jeffrey Andolina
Study Contact InformationStudy Coordinator: katherine Nedrow
Phone: (585) 275-3893
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search